Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Recap: Gain Therapeutics Q1 Earnings

Author: Benzinga Insights | May 16, 2022 05:46pm

Gain Therapeutics (NASDAQ:GANX) reported its Q1 earnings results on Monday, May 16, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Gain Therapeutics beat estimated earnings by 24.32%, reporting an EPS of $-0.28 versus an estimate of $-0.37.

Revenue was up $39.73 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.23 which was followed by a 7.28% drop in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Gain Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: GANX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist